Elevated triglyceride glucose-body mass index is associated with a higher risk of reduced cumulative live birth and adverse pregnancy outcomes in women undergoing assisted reproductive technology: a retrospective cohort study - Scorecard - MDSpire
Advertisement
Elevated triglyceride glucose-body mass index is associated with a higher risk of reduced cumulative live birth and adverse pregnancy outcomes in women undergoing assisted reproductive technology: a retrospective cohort study
Clinical Scorecard: Association of Elevated Triglyceride Glucose-Body Mass Index with Increased Risk of Lower Cumulative Live Birth Rates and Adverse Pregnancy Outcomes in Women Receiving Assisted Reproductive Technology: A Retrospective Cohort Analysis
At a Glance
Category
Detail
Condition
Insulin resistance and reproductive outcomes
Key Mechanisms
TyG-BMI as a marker of insulin resistance
Target Population
Women undergoing ART
Care Setting
Reproductive and Genetic Hospital of CITIC-Xiangya, China
Key Highlights
Higher TyG-BMI is associated with lower cumulative live birth rates.
Increased risks of first-trimester miscarriage and second- or third-trimester fetal loss linked to higher TyG-BMI.
Guideline-Based Recommendations
Diagnosis
Use TyG-BMI as a marker for insulin resistance in ART patients.
Management
Monitor TyG-BMI in women undergoing ART.
Monitoring & Follow-up
Regular assessment of TyG-BMI in ART populations.
Risks
Higher TyG-BMI correlates with increased risks of miscarriage and fetal loss.
Patient & Prescribing Data
Women aged 20 to 45 years undergoing ART
Clinical Best Practices
Incorporate TyG-BMI assessment in evaluations of women undergoing ART.
